Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
3.040
+0.270 (9.75%)
Mar 14, 2025, 4:00 PM EST - Market closed

Humacyte Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Mar '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
391294218747131-
Market Cap Growth
114.24%35.19%-70.86%471.21%--
Enterprise Value
4502519754939-
Last Close Price
3.042.842.117.2510.17-
PS Ratio
--139.03591.2787.68-
PB Ratio
-6.1421.721.866.111.85-
P/TBV Ratio
-21.721.866.11--
EV/Sales Ratio
--61.82434.3125.88-
Debt / Equity Ratio
-1.254.290.430.420.410.21
Asset Turnover
--0.010.010.01-
Quick Ratio
0.984.367.7620.423.568.70
Current Ratio
1.104.527.8820.753.698.76
Return on Equity (ROE)
--169.81%-10.01%-27.46%-65.58%-
Return on Assets (ROA)
-53.23%-36.44%-21.54%-25.81%-29.32%-
Return on Capital (ROIC)
-128.12%-50.64%-31.01%-37.20%-31.18%-
Earnings Yield
-39.08%-37.66%-5.50%-3.55%-50.88%-
FCF Yield
-23.59%-25.70%-33.17%-10.90%-42.75%-
Buyback Yield / Dilution
-9.01%-0.36%-157.82%-593.25%71.34%-
Total Shareholder Return
-9.01%-0.36%-157.82%-593.25%71.34%-
Source: S&P Capital IQ. Standard template. Financial Sources.